Small Intestinal Bacterial Overgrowth in Chronic Floxing
One culprit that is often overlooked in chronic Fluoroquinolone toxicity is small intestinal bacterial overgrowth, or SIBO.
Year: 2016
Metabolomics: Hope For Chronic Floxing?
I believe that metabolomics is going to open a door for giving us insight into chronic fluoroquinolone toxicity and provide insight into treatment options for those chronically suffering.
Honesty is Better Than Sugar Coated Truth
If doctors and politicians only see the watered down messages they will not be motivated to change the status quo and more than likely it will be perpetuated indefinitely.
Hillary Clinton and Levaquin, A Teachable Moment
This is a good high profile opportunity for us to continue to warn the general public, family and friends about the dangers posed by the Fluoroquinolones.
Fluoroquinolone Use In The Emergency Room: Go To The ER And Get “Floxed”
One hundred patients who went to the Emergency Room and received a Fluoroquinolone were studied, in ninety nine of those cases, errors were made with the Fluoroquinolone!
FDA Fails to Go The Distance, Yet Again
I am ecstatic about the new label changes. But given the FDA’s past track record, I will not happy until every medical professional, who has the ability to prescribe a FQ, is familiar with the label changes and safety precautions.
Six New Quinolones In Development
It is this author’s opinion, that anything based on the quinoline pharmacophore synthetic or not, whose history can be traced all the way back to the cinchona tree, has a unique propensity for toxic damage in the human body.
FDA Shell Game? I Hope Not
I think it was no coincidence that the FDA denied the mitochondrial citizen petition during the same time frame that they approved label changes. Right now the FDA is not acknowledging even the risk of mitochondrial toxicity.
FDA Changes Fluoroquinolone Label But Denies Citizen Petition on Mitochondrial Toxicity
On Thursday May 12, 2016 the FDA contacted those who have been pursuing label changes for the Fluoroquinolones and issued a public statement that the FDA is requiring label changes for antibacterial drugs called fluoroquinolones
Another Heart Attack…
On March 1, 2016 a week before my 55th birthday I suffered a second heart attack, thanks to the fluoroquinolones.
Dr. Bennett Publishes Paper on Fluoroquinolone Neuropsychiatric & Mitochondrial Toxicity
Dr. Charles Bennett has been able to successfully publish a paper titled “Fluoroquinolone-Related Neuropsychiatric and Mitochondrial Toxicity: a collaborative investigation by scientists and members of a social network.”